Serum enkephalin-degrading aminopeptidase activity in N-methyl nitrosourea-induced rat breast cancer

Anticancer Research

Volumn 25, Issue 1 A, 2005, Pages 193-196

  Carrera, María Pilar ^a   Ramírez Expósito, María Jesús ^a   Valenzuela, Maria Teresa ^b   Dueñas, Basilio ^c   García, María Jesús ^a   Mayas, María Dolores ^a   Martínez Martos, José Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b Distrito Sanitario Granada   (Spain)

^c Unidad de Patología Mamaria   (Spain)

Author keywords

Breast cancer; Enkephalin; Enkephalinase; N methyl nitrosourea

Indexed keywords

AMINOPEPTIDASE; BIOLOGICAL MARKER; ENKEPHALIN; LEUCINE ENKEPHALIN; METENKEPHALIN; METHYLNITROSOUREA; NAPHTHYL GROUP; PROTEINASE; STEROID RECEPTOR; TYROSYL 2 NAPHTHYLAMIDE; TYROSYLAMINOPEPTIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME RELEASE; ENZYME SUBSTRATE; EXPERIMENTAL MODEL; FEMALE; FLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; RAT; RAT STRAIN; REGULATORY MECHANISM;

AMINOPEPTIDASES; ANIMALS; DISEASE PROGRESSION; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL;

EID: 16344393320     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Russo J and Russo IH: Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 39: 7-20, 1996.
2. Russo IH and Russo J: Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104: 938-967, 1996.
3. Hatzoglou A, Bakogeorgou E, Kampa M, Panagiotou S, Martin PM, Loukas S and Castanas E: Somatostatin and opioid receptors in mammary tissue. Role in cancer cell growth. Adv Exp Med Biol 480: 55-63, 2000.
4. Hersh LB: Degradation of enkephalins: the search for an enkephalinase. Mol Cell Biochem 47: 35-43, 1982.
5. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC and Beaumont A: Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45: 87-146, 1993.
6. Fernandez D, Valdivia A, Irazusta J, Ochoa C and Casis L: Peptidase activities in human semen. Peptides 23: 461-468, 2002.
7. Russo IH and Russo J: Hormonal approach to breast cancer prevention. J Cell Biochem 77: 1-6, 2000.
8. Gullino PM, Pettigrew HM and Grantham FH: N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54: 401-414, 1975.
9. McCormick DL, Adamowski CB, Fiks A and Moon RC: Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41: 1690-1694, 1981.
10. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45: 3415-3443, 1985.
11. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62: 244-278, 1990.
12. Russo J, Russo IH, Rogers AE, van Zwieten MJ and Gusterson B: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the mammary gland. IARC Sci Publ 47-78, 1990.
13. Rivera ES, Andrade N, Martin G, Melito G, Cricco G, Mohamad N, Davio C, Caro R and Bergoc RM: Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. Cancer Lett 86: 223-228, 1994.
14. McLaughlin PJ, Levin RJ and Zagon IS: The opioid growth factor receptor in human head and neck squamous cell carcinoma. Int J Mol Med 5: 191-196, 2000.
15. McLaughlin PJ, Zagon IS and Skitzki J: Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor. Int J Oncol 14: 373-380, 1999.
16. 5]enkephalin) prevents the incidence and retards the growth of human colon cancer. Am J Physiol 271: R780-786, 1996.
17. Zagon IS and McLaughlin P: Endogenous opioids and the growth regulation of a neural tumor. Life Sci 43: 1313-1318, 1988.
18. Zagon IS and McLaughlin PJ: Endogenous opioid systems regulate growth of neural tumor cells in culture. Brain Res 490: 14-25, 1989.
19. Zagon IS and McLaughlin PJ: Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res 542: 318-323, 1991.
20. Zagon IS, Smith JP and McLaughlin PJ: Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int J Oncol 14: 577-584, 1999.
21. Russo J, Tahin Q, Lareef MH, Hu YF and Russo IH: Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ Mol Mutagen 39: 254-263, 2002.
22. Russo J, Lareef MH, Tahin Q, Hu YF, Slater C, Ao X and Russo IH: 17Beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol 80: 149-162, 2002.
23. Russo J, Lareef H, Tahin Q and Russo IH: Pathways of carcinogenesis and prevention in the human breast. Eur J Cancer 38 Suppl 6: S31-32, 2002.
24. Zagon IS and McLaughlin P: The role of endogenous opioids and opioids receptors in human and animal cancers. In: Stress and Immunity. (Plotnikoff NP, Murgo AJ, Faith RE and Wybran J, eds). Caldwell, NJ, CRC Press. 1991, pp 343-356.
25. Zagon IS and McLaughlin P: Opioid growth factor in the developing nervous system. In: Receptors in the Developing Nervous System. (Zagon IS and McLaughlin P, eds). London, Chapman and Hall. 1993, pp 39-62.
26. 5-enkephalin, and the etiology, pathogenesis, and treatment of gastrointestinal cancer. In: Cytokines, Stress and Immunity. (Plotnikoff NP, Faith RE, Murgo AJ and Good R, eds). Boca Raton, FL, CRC Press. 1999, pp 245-260.
27. Zagon IS, Verderame MF and McLaughlin PJ: The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev 38: 351-376, 2002.
28. Leslie FM: Methods used for the study of opioid receptors. Pharmacol Rev 39: 197-249, 1987.
29. Pert CB and Snyder SH: Opiate receptor: demonstration in nervous tissue. Science 179: 1011-1014, 1973.
30. Maneckjee R, Biswas R and Vonderhaar BK: Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res 50: 2234-2238, 1990.
31. Panagiotou S, Hatzoglou A, Calvo F, Martin PM and Castanas E: Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems. J Cell Biochem 71: 416-428, 1998.
32. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Garcia MJ, Mayas MD and Martinez-Martos JM: Serum pyrrolidone carboxypeptidase activity in N-methyl-nitrosourea induced rat breast cancer. Horm Metab Res 35: 502-505, 2003.
33. Huirne JA and Lambalk CB: Gonadotropin-releasing-hormone-receptor antagonists. Lancet 358: 1793-1803, 2001.
34. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Garcia MJ, Mayas MD and Martínez-Martos JM: Serum oxytocinase activity is related to tumor growth parameters in N-methyl nitrosourea induced rat breast cancer. Life Sci 75: 1369-1377, 2004.
35. Garcia-López MJ, Martínez-Martos JM, Mayas MD, Carrera MP and Ramirez-Exposito MJ: Influence of hormonal status on female mice enkephalin-degrading aminopeptidase activity in the HPA axis. Arch Neurosci (Mex) 8: 60-63, 2003.
36. Garcia-Lopez MJ, Martínez-Martos JM, Mayas MD, Carrera MP and Ramirez-Exposito MJ: Effects of orchidectomy and testosterone replacement on mouse enkephalin-degrading aminopeptidase activity in the HPA axis. Gen Comp Endocrinol 134: 303-307, 2003.